KIF20A and cancer: To this aim, human KIF20A-derived and HLA-A2-restricted cytotoxic T lymphocyte (CTL) epitopes were identified using HLA-A2 transgenic mice (Tgm), and the ability of peptides to induce KIF20A-reactive human CTLs that kill cancer cells and the safety not to induce autoimmune responses in the mouse were investigated.